Active substanceAlgeldrat + Magnesium hydroxideAlgeldrat + Magnesium hydroxide
Similar drugsTo uncover
  • Agiflux
    pills inwards 
  • Almagel®
    suspension inwards 
    AKTAVIS, LTD.     Russia
  • Alumag®
    pills inwards 
    GEDEON RICHTER, OJSC     Hungary
  • Gastracid®
    pills inwards 
    VALEANT, LLC     Russia
  • Maalox®
    suspension inwards 
  • Maalox®
    pills inwards 
  • Maalox® mini
    suspension inwards 
  • Dosage form: & nbspchewing tablets
    Composition:

    For one tablet:

    Active substances:

    Magnesium hydroxide 400.00 mg

    Algeldrate (Aluminum hydrated oxide) - 400.00 mg in terms of aluminum oxide - 214.00 mg

    Excipients: mannitol 10.00 mg, sorbitol 183.00 mg, sodium saccharinate 3.00 mg, sucrose 186.40 mg, corn starch 5.60 mg, flavoring mint 10.00 mg, magnesium stearate 6.00 mg.

    Description:

    Tablets are round.

    Tablets are flat round with a beveled edge of white or white with a greyish-yellowish-greenish hue of color, with a slight smell of mint, on both sides of the engraving NP against the background of a tree.

    Tablets are square.

    Flat square tablets with a beveled edge of white or white with a greyish-yellowish-greenish hue of color, with a slight smell of mint, on both sides of the engraving NP against the background of a tree.

    Pharmacotherapeutic group:Antacid agent
    ATX: & nbsp

    A.02.A.X   Antacids in combination with other drugs

    Pharmacodynamics:

    Combined drug for the elimination of heartburn and stomach pain, the effect of which is due to its constituent components.

    Algeldrat has an antacid, adsorbing, enveloping, carminative effect. Magnesium hydroxide has a slight laxative effect.

    The drug neutralizes free hydrochloric acid in the stomach, reduces the activity of gastric juice; Inactivates pepsin and binds bile acids that enter the stomach as a result of reflux from the duodenum, exerts a protective effect on the mucous membrane of the stomach and duodenum; accelerates the motility of the stomach and all parts of the intestine. Does not cause secondary hypersecretion of hydrochloric acid and alkalosis.

    Pharmacokinetics:

    Absorption is low.

    Indications:

    - Stomach ulcer and duodenal ulcer in the phase of exacerbation.

    - Acute gastritis with increased and normal secretory function in the exacerbation phase, acute duodenitis.

    - Hernia of the esophageal opening of the diaphragm, reflux esophagitis.

    - Discomfort, heartburn and epigastric pain with inaccuracy in the diet, after taking medications, including glucocorticosteroids and non-steroidal anti-inflammatory drugs, and after consuming coffee, nicotine, alcohol.

    Contraindications:

    Hypersensitivity to the components of the drug. Deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption. Hypofosfatemia, pronounced impaired kidney function, children under 10 years of age, Alzheimer's disease, pregnancy.

    Carefully:During lactation.
    Dosing and Administration:

    Inside. Tablets should be chewed and kept in the mouth until completely absorbed.

    Adults and children over 15 years of age: 1-2 tablets 4 times a day 1 hour after meals and in the evening before bed or when there is discomfort, epigastric pain, heartburn. With gastric ulcer, the drug should be taken 30 minutes before meals. The maximum daily dose is 12 tablets.

    Children from 10 to 15 years prescribe half the recommended dose for adults.

    For prevention - 1 tablet 15 minutes before taking medications that irritate the mucous membrane of the esophagus, stomach and duodenum.

    Duration of treatment should not exceed 15-20 days.

    Side effects:

    Constipation, nausea, vomiting, stomach pains of a spastic nature, change. gustatory sensations, hypermagnesia, hypophosphatemia, hypocalcemia, hypercalciuria, osteomalacia, osteoporosis, hyperaluminia, encephalopathy, nephrocalcinosis, renal dysfunction, allergic reactions. In patients with concomitant renal failure - thirst, lowering blood pressure, hyporeflexia.

    Overdose:

    Symptoms

    The formation of kidney stones, the appearance of severe constipation, drowsiness, hypermagnesia. There may also be signs of metabolic alkalosis: mood changes, numbness or pain in the muscles, nervousness and fatigue, unpleasant gustatory sensations.

    Treatment

    It is necessary to immediately take measures to quickly remove the drug: rinse the stomach, induce vomiting, take Activated carbon.

    Interaction:

    Can adsorb some medicines, thereby reducing their absorption. Reduces and slows the absorption of digoxin, indomethacin, salicylates, chlorpromazine, phenytoin, H2-histamine receptor blockers, beta-adrenoblockers, diflunisal, isoniazid,antibiotics of the tetracycline series, quinolones (ciprofloxacin, norfloxacin, ofloxacin, enoxacin, grapafloxacin, etc.), azithromycin, cefpodoxim, pivapicillin, rifampicin, indirect anticoagulants, barbiturates, fexofenadine, dipyridamole, zalcitabine, bile acids - chenodeoxycholic and ursodeoxycholic, penicillamine, iron preparations and lithium, quinidine, lansoprazole, mexiletine, ketoconazole.

    With simultaneous reception with preparations coated with an enteric-coated shell, increased alkalinity of the gastric juice can lead to an accelerated disruption of the envelope and cause irritation of the stomach and duodenum.

    M-holinoblokatory, slowing the emptying of the stomach, strengthen and lengthen the action of the drug.

    Special instructions:

    The interval between taking Gastricid® and other medications should be 1-2 hours.

    With more prolonged use (more than 20 days), regular medical supervision is necessary. The preparation contains sorbitol, which is contraindicated in congenital intolerance to fructose.

    Effect on the ability to drive transp. cf.and fur:

    The drug does not affect the ability to drive vehicles and engage in other activities that require concentration and speed of psychomotor reactions.

    Form release / dosage:

    Tablets are chewable.

    Packaging:

    For round tablets: 10 tablets each in a PVC / A1 blister; 1, 2, 3, 4, 5 blisters in a cardboard box with instructions for use.

    For square tablets: 4, 6, 8 tablets in a PVC / A1 blister; on 1,2, 3,4, 5 blisters in a cardboard pack with the instruction on application.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children!

    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N011015
    Date of registration:05.05.2011 / 30.06.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:VALEANT, LLC VALEANT, LLC Russia
    Manufacturer: & nbsp
    Representation: & nbspVALEANT LLC VALEANT LLC Russia
    Information update date: & nbsp15.03.2017
    Illustrated instructions
      Instructions
      Up